Skip to main content
logo
Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.080
0.00 (0.00%)
At close: Apr 2, 2026, 4:00 PM EDT
1.083
+0.003 (0.24%)
After-hours: Apr 2, 2026, 7:55 PM EDT

Clearmind Medicine Ratios and Metrics

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Market Cap
2562--
Market Cap Growth
-62.13%-15.16%166.72%---
Enterprise Value
-8.081.2-0.92-3.2900
Last Close Price
1.0831.8255.60146.40--
PE Ratio
--1.05-0.82-0.09--
PB Ratio
0.204.221.912.26--
P/TBV Ratio
0.053.391.390.75--
P/FCF Ratio
--1.06-1.22-0.35--
P/OCF Ratio
--1.06-1.22-0.35--
EV/EBITDA Ratio
--0.210.160.53--
EV/EBIT Ratio
--0.210.160.52--
EV/FCF Ratio
--0.250.190.52--
Debt / Equity Ratio
-1.480.01000
Debt / EBITDA Ratio
0.00-0.32-0.01--0.01-
Debt / FCF Ratio
0.00-0.38-0.01--0.01-
Net Debt / Equity Ratio
-1.25-3.19-2.19-5.610.26-0.96
Net Debt / EBITDA Ratio
1.330.681.200.880.051.38
Net Debt / FCF Ratio
1.860.801.400.880.081.77
Quick Ratio
3.711.211.701.160.2213.33
Current Ratio
3.791.221.721.170.2213.78
Return on Equity (ROE)
-140.81%-179.39%-256.89%14071.85%-497.52%-132.37%
Return on Assets (ROA)
-91.40%-86.56%-93.73%-186.33%-251.52%-121.98%
Return on Invested Capital (ROIC)
2673.20%2699.92%3073.54%957.31%1341.41%-3458.41%
Return on Capital Employed (ROCE)
-166.07%-262.58%-279.73%10289.14%-451.09%-130.83%
Earnings Yield
-294.34%-95.38%-121.94%-1163.28%--
FCF Yield
-246.20%-94.13%-81.95%-283.49%--
Buyback Yield / Dilution
-305.49%-63.98%-1431.07%-367.24%-40.19%-70.50%
Total Shareholder Return
-305.49%-63.98%-1431.07%-367.24%-40.19%-70.50%
Updated Jan 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q